Subject: Re: Examples needed against Soft Patents
From: "Michael R. Bernstein" <webmaven@cox.net>
Date: Wed, 22 Dec 2004 06:40:37 -0800

On Tue, 2004-12-21 at 23:25, Stephen J. Turnbull wrote:
> >>>>> "Michael" == Michael R Bernstein <webmaven@cox.net> writes:
> 
>     Michael> Doesn't that make open peer-review *more* important for
>     Michael> pharmaceuticals?
> 
> Not particularly.  According to Steve McConnell, "open" (ie, "I'll
> look at it if and when I feel like it") peer review can't hold a
> candle to review by a team of expert professionals.  This is going to
> hold even more true for medical experiments.  Making it open (ie,
> requiring publication of the patent application as well as the patent
> awarded) is very unlikely to save any lives.

I was thinking more along the lines of requiring publication of the
clinical trial or other reproducible data as part of the patent
application.

-- 
Michael R. Bernstein <webmaven@cox.net>